data_1n8m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n8m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.567 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.761 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.0 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.761 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.997 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 28' ' ' ILE . 54.0 m-80 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.685 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.685 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 23' ' ' PRO . 6.3 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.73 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.654 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.654 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 17' ' ' GLN . 3.6 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.573 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 17' ' ' GLN . 1.0 OUTLIER -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.463 HG13 ' ND2' ' A' ' 29' ' ' ASN . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' ND2' HG13 ' A' ' 28' ' ' ILE . 51.6 m-80 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.755 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.65 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD3' ' C ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.755 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.459 ' NH1' HG21 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.459 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 28' ' ' ILE . 50.0 m-80 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 HG21 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.725 HE21 ' HB3' ' A' ' 23' ' ' PRO . 32.7 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HB3' HE21 ' A' ' 17' ' ' GLN . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HZ2' ' HB2' ' A' ' 30' ' ' LYS . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.892 0.377 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 3.8 pm0 -66.4 130.27 42.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.268 175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.69 102.29 13.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.334 0.588 . . . . 0.0 111.289 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt -79.34 106.73 10.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.655 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -115.8 -41.47 3.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.72 -142.41 43.61 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.56 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.69 69.02 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.428 0.633 . . . . 0.0 109.321 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.251 1.139 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.711 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.518 HG21 ' O ' ' A' ' 32' ' ' CYS . 76.5 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.364 0.602 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 64.33 31.33 12.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.735 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.45 77.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.985 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt -79.11 104.23 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.567 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.76 -39.76 84.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.67 -143.57 19.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.172 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -93.45 54.3 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 111.401 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.39 179.172 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.47 48.0 0.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.114 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.21 76.36 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.463 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.761 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt -78.79 106.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.0 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.761 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -104.66 -39.36 6.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 80.82 -154.13 35.4 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.815 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.2 m -109.61 29.83 7.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.578 . . . . 0.0 111.135 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.556 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.1 pt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.153 0.502 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' CD ' HH12 ' A' ' 19' ' ' ARG . 35.5 tt0 -67.16 134.47 51.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.308 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.49 81.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 111.13 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt -78.27 103.7 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.997 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 28' ' ' ILE . 54.0 m-80 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.35 -31.51 58.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.04 -155.54 30.17 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.8 80.74 6.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.172 0.511 . . . . 0.0 110.787 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.165 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.4 HD12 ' HD2' ' A' ' 33' ' ' LYS . 16.0 mt . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 122.143 0.973 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.88 56.98 3.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.168 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.17 64.81 1.7 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.494 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt -78.29 109.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.685 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.685 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 23' ' ' PRO . 6.3 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.4 ' HD2' HD12 ' A' ' 1' ' ' ILE . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 -105.85 -22.34 12.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.04 -135.21 50.53 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.228 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 m -147.64 110.0 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.03 179.003 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 41.1 pt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -65.8 119.31 11.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 109.918 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.67 85.61 7.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.485 . . . . 0.0 111.397 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.73 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt -78.73 103.73 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.654 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.654 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 17' ' ' GLN . 3.6 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -88.08 -38.92 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.26 -129.4 47.53 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.752 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.51 104.16 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.247 0.939 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.96 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.008 0.432 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 167.74 10.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.97 75.02 8.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.167 -174.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt -79.64 104.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.573 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 17' ' ' GLN . 1.0 OUTLIER -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.463 HG13 ' ND2' ' A' ' 29' ' ' ASN . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' ND2' HG13 ' A' ' 28' ' ' ILE . 51.6 m-80 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 -80.17 -43.25 21.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.5 166.7 16.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.25 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 29.2 m -149.48 73.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.863 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.286 0.565 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.94 30.14 7.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.24 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.43 76.18 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.64 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.755 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt -77.86 97.13 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.65 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD3' ' C ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.755 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB2' HG23 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.35 -34.63 65.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.53 -168.5 26.65 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.173 -173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.7 p -131.95 20.19 4.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.327 1.061 . . . . 0.0 109.133 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.395 -175.624 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.216 0.532 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 19' ' ' ARG . 9.9 pt-20 -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.65 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.82 6.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt -79.28 102.99 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' NH1' HG21 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.459 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 28' ' ' ILE . 50.0 m-80 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 HG21 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.41 -33.58 19.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 57.43 -124.43 35.93 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.4 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.9 m -132.08 31.2 4.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.247 -175.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.24 147.48 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 110.907 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.14 91.74 7.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.357 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt -78.96 99.26 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.725 HE21 ' HB3' ' A' ' 23' ' ' PRO . 32.7 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HB3' HE21 ' A' ' 17' ' ' GLN . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HZ2' ' HB2' ' A' ' 30' ' ' LYS . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -88.42 -26.39 22.16 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.57 32.05 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.397 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.3 p -132.06 27.24 4.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.828 0.823 . . . . 0.0 109.969 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.09 -176.218 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.765 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 40.8 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.543 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.981 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.529 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.738 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.694 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 45.0 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.664 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 23' ' ' PRO . 30.3 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.422 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 28' ' ' ILE . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.1 m120 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.768 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.698 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' NH1' HG23 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.8 m120 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.892 0.377 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 3.8 pm0 -66.4 130.27 42.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.268 175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.69 102.29 13.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.334 0.588 . . . . 0.0 111.289 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt -79.34 106.73 10.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -115.8 -41.47 3.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 57.72 -142.41 43.61 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.56 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.69 69.02 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.428 0.633 . . . . 0.0 109.321 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.251 1.139 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.711 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.531 HG21 ' O ' ' A' ' 32' ' ' CYS . 76.5 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.364 0.602 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 64.33 31.33 12.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.735 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.45 77.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.985 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt -79.11 104.23 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.76 -39.76 84.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.67 -143.57 19.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.172 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -93.45 54.3 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 111.401 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.39 179.172 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.47 48.0 0.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.114 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.21 76.36 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.463 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.765 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt -78.79 106.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 40.8 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -104.66 -39.36 6.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 80.82 -154.13 35.4 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.815 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.2 m -109.61 29.83 7.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.578 . . . . 0.0 111.135 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.556 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.1 pt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.153 0.502 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' CD ' HH12 ' A' ' 19' ' ' ARG . 35.5 tt0 -67.16 134.47 51.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.308 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.49 81.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 111.13 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt -78.27 103.7 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.543 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.981 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.529 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.35 -31.51 58.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.04 -155.54 30.17 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.8 80.74 6.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.172 0.511 . . . . 0.0 110.787 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.165 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.419 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.0 mt . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 122.143 0.973 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.5 pm0 -83.88 56.98 3.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.17 64.81 1.7 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.494 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.738 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt -78.29 109.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.694 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 45.0 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 1' ' ' ILE . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 -105.85 -22.34 12.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.04 -135.21 50.53 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.228 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 m -147.64 110.0 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.03 179.003 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 41.1 pt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -65.8 119.31 11.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 109.918 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.67 85.61 7.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.485 . . . . 0.0 111.397 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt -78.73 103.73 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.664 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 23' ' ' PRO . 30.3 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.422 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 28' ' ' ILE . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -88.08 -38.92 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 60.26 -129.4 47.53 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.752 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.51 104.16 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.247 0.939 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.96 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.008 0.432 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 167.74 10.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.97 75.02 8.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.167 -174.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt -79.64 104.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.1 m120 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 -80.17 -43.25 21.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.5 166.7 16.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.25 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 29.2 m -149.48 73.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.863 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.286 0.565 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.94 30.14 7.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.24 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.43 76.18 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.64 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt -77.86 97.13 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.768 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.35 -34.63 65.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.53 -168.5 26.65 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.173 -173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.7 p -131.95 20.19 4.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.327 1.061 . . . . 0.0 109.133 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.395 -175.624 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.216 0.532 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' CD ' HH12 ' A' ' 19' ' ' ARG . 9.9 pt-20 -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.65 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.82 6.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.698 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt -79.28 102.99 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' NH1' HG23 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.8 m120 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.41 -33.58 19.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 57.43 -124.43 35.93 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.4 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.9 m -132.08 31.2 4.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.247 -175.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.24 147.48 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 110.907 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.14 91.74 7.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.357 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt -78.96 99.26 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -88.42 -26.39 22.16 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.57 32.05 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.397 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.3 p -132.06 27.24 4.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.828 0.823 . . . . 0.0 109.969 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.09 -176.218 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.765 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.0 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.543 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.981 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 29' ' ' ASN . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.589 HD22 HG13 ' A' ' 28' ' ' ILE . 54.0 m-80 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.529 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.738 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.694 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.3 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.664 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 17' ' ' GLN . 3.6 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.422 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 28' ' ' ILE . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 17' ' ' GLN . 1.0 OUTLIER -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' ND2' ' A' ' 29' ' ' ASN . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.48 ' ND2' HG13 ' A' ' 28' ' ' ILE . 51.6 m-80 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.768 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.698 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' NH1' HG23 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.522 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' A' ' 28' ' ' ILE . 50.0 m-80 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.768 HE21 ' HB3' ' A' ' 23' ' ' PRO . 32.7 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.768 ' HB3' HE21 ' A' ' 17' ' ' GLN . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.892 0.377 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 3.8 pm0 -66.4 130.27 42.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.268 175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.69 102.29 13.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.334 0.588 . . . . 0.0 111.289 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 63.8 mt -79.34 106.73 10.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -77.04 144.11 38.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.028 0.442 . . . . 0.0 110.916 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.653 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -143.8 134.33 24.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.337 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.94 -26.74 48.25 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . -149.72 177.9 27.57 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -72.0 -30.68 65.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 109.825 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 74.9 mtm180 -69.47 -16.04 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.005 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -85.04 -4.91 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.685 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.1 m -104.2 -16.44 15.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.119 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 18.9 m-30 -61.77 -50.76 71.05 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.678 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -51.19 -59.1 8.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 27.8 Cg_endo -63.04 -52.93 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.76 1.64 . . . . 0.0 112.585 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 40.3 m -67.03 -34.52 77.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.81 -37.42 73.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -69.9 -38.04 76.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 110.627 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -72.99 -51.21 19.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.998 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.3 p -97.54 -42.32 7.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 111.993 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.1 -18.77 6.14 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.71 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 81.1 m -130.98 146.9 64.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.6 1.6 9.16 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.007 2.471 . . . . 0.0 113.402 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -54.74 104.58 0.12 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.424 0.452 . . . . 0.0 110.688 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.97 158.77 41.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.129 0.49 . . . . 0.0 111.179 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.43 127.73 51.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.805 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.27 77.57 9.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.55 139.48 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.613 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.13 28.42 17.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.322 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 62.04 24.96 14.92 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.2 p -134.67 138.18 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.401 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.653 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 92.0 m -72.66 113.6 9.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.231 0.539 . . . . 0.0 111.336 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -98.22 93.76 6.41 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m -80.81 136.39 36.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.562 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -115.8 -41.47 3.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.847 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 57.72 -142.41 43.61 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.56 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.69 69.02 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.428 0.633 . . . . 0.0 109.321 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.251 1.139 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.711 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.531 HG21 ' O ' ' A' ' 32' ' ' CYS . 76.5 mt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.364 0.602 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 64.33 31.33 12.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.735 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.45 77.64 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.985 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 79.7 mt -79.11 104.23 6.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 14.9 mmt180 -70.57 130.92 43.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 1.9 p -131.61 160.48 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.355 0.598 . . . . 0.0 112.26 -172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.62 39.94 2.54 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.09 160.54 8.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.899 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -66.54 -34.29 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 109.877 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 41.2 mtp180 -72.0 -8.47 54.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.696 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -96.09 -7.94 34.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.604 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.1 m -97.73 -16.57 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.924 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 20.0 m-30 -61.84 -54.75 37.85 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.457 -175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -52.27 -55.04 35.2 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.902 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 18.6 Cg_endo -60.85 -60.58 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.81 1.673 . . . . 0.0 112.34 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.9 m -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -172.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -66.12 -46.66 76.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 18.1 tptm -66.71 -30.95 71.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 110.585 -175.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 22.4 mtp180 -76.45 -54.02 7.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.451 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.9 p -91.8 -34.12 14.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.8 -31.05 5.49 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.623 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.6 m -116.52 143.5 31.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.562 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.58 8.8 4.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.149 2.566 . . . . 0.0 113.574 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.23 105.98 1.23 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.459 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.21 144.73 14.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.621 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -134.32 143.66 47.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.857 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.9 t -92.69 86.22 5.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.773 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -113.03 136.93 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.944 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.562 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 18.8 mmtt 67.79 10.01 7.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.837 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -121.24 127.55 51.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.592 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.7 m -61.54 119.17 8.08 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.742 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -97.68 82.39 3.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.0 m -69.0 98.19 0.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.76 -39.76 84.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.052 0.454 . . . . 0.0 109.953 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.67 -143.57 19.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.172 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -93.45 54.3 2.04 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 111.401 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.39 179.172 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.47 48.0 0.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.114 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.21 76.36 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.463 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.765 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 68.2 mt -78.79 106.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -70.85 120.39 16.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.181 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 4.2 p -125.26 147.53 49.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.602 -175.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.42 19.08 49.42 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.25 163.38 14.91 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -67.22 -27.61 67.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.18 0.49 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 68.2 mtp180 -75.01 -10.51 59.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.973 0.416 . . . . 0.0 110.559 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.11 -2.3 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.5 m -107.43 -10.98 15.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.998 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 m-30 -69.34 -54.07 16.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.85 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.8 tmt_? -52.61 -53.98 47.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 17.0 Cg_endo -58.8 -58.75 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 121.683 1.589 . . . . 0.0 112.339 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 61.6 m -66.68 -35.96 81.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.0 tt0 -68.33 -32.21 72.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.175 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -76.27 -46.22 28.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.314 176.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 19.2 mtp180 -67.46 -52.13 43.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.825 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.0 p -97.25 -11.99 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.69 62.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m -131.54 148.15 68.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 122.66 -0.318 . . . . 0.0 111.086 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.72 5.89 6.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.178 2.585 . . . . 0.0 113.371 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.28 96.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.0 110.079 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.2 142.54 26.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.224 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -122.04 129.12 52.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.156 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.53 90.45 7.23 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 tp -112.23 132.4 61.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 54.71 40.98 32.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? 68.39 13.14 8.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.6 p -130.98 127.16 37.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.02 0.438 . . . . 0.0 111.245 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.0 m -67.1 117.15 8.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.577 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -99.95 97.86 8.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 2.9 m -78.32 131.73 37.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.136 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -104.66 -39.36 6.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 111.279 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 80.82 -154.13 35.4 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.815 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.2 m -109.61 29.83 7.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.578 . . . . 0.0 111.135 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.556 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.1 pt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.153 0.502 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' CD ' HH12 ' A' ' 19' ' ' ARG . 35.5 tt0 -67.16 134.47 51.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.308 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.49 81.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.027 0.442 . . . . 0.0 111.13 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 67.9 mt -78.27 103.7 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 30' ' ' LYS . 32.7 mmt180 -67.73 130.12 42.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.701 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 6.3 p -135.62 158.33 44.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.385 0.612 . . . . 0.0 111.841 -174.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.97 31.37 5.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.01 150.72 5.63 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 m -66.9 -29.61 69.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.338 0.569 . . . . 0.0 110.205 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 19.3 mtp180 -66.12 -19.69 65.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.498 174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.53 -13.6 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.676 0.75 . . . . 0.0 109.087 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.4 m -93.14 -15.89 25.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.782 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 23.1 m-30 -61.74 -58.63 7.25 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.274 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 2.7 tmt_? -52.36 -56.1 25.6 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.641 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 8.4 Cg_endo -53.64 -61.5 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.923 1.749 . . . . 0.0 112.578 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.89 -35.93 82.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.43 -174.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.543 HE21 ' HB3' ' A' ' 23' ' ' PRO . 14.2 tt0 -64.92 -42.83 94.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.209 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.981 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.6 mmpt? -78.28 -22.57 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.722 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 20.3 mtp180 -83.11 -37.61 23.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.185 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -107.98 -32.36 7.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.28 -14.81 18.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.933 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.0 m -135.87 145.05 51.16 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.329 . . . . 0.0 110.769 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HB3' HE21 ' A' ' 17' ' ' GLN . 65.7 Cg_endo -83.97 11.98 3.15 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.379 2.719 . . . . 0.0 113.65 -173.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.66 98.75 0.1 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.884 0.374 . . . . 0.0 110.441 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.46 145.58 22.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.055 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -125.19 135.61 52.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.62 69.44 10.64 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.589 HG13 HD22 ' A' ' 29' ' ' ASN . 10.3 tp -84.11 119.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.463 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.589 HD22 HG13 ' A' ' 28' ' ' ILE . 54.0 m-80 51.59 46.98 25.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.51 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.529 ' HD2' ' HD2' ' A' ' 5' ' ' ARG . 2.9 ttmm 65.02 25.89 12.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.5 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.2 p -140.89 131.79 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.461 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 83.7 m -73.68 122.29 22.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.256 0.551 . . . . 0.0 111.95 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -99.1 93.79 6.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.7 m -82.13 102.66 11.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.821 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.35 -31.51 58.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.957 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.04 -155.54 30.17 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.8 80.74 6.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.172 0.511 . . . . 0.0 110.787 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.165 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.419 HD13 ' HD2' ' A' ' 33' ' ' LYS . 16.0 mt . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 122.143 0.973 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.5 pm0 -83.88 56.98 3.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.17 64.81 1.7 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.494 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.738 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 71.8 mt -78.29 109.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 41.0 mmt180 -76.06 136.77 39.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.458 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 12.0 p -144.27 152.93 41.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.876 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.69 13.82 17.65 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 170.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 175.8 165.14 31.29 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -64.81 -30.09 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.058 0.429 . . . . 0.0 110.634 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.694 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 48.4 mtm180 -73.68 -13.16 60.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.183 0.515 . . . . 0.0 110.629 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.1 m-20 -82.94 -9.31 59.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.619 0.723 . . . . 0.0 109.057 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.7 m -104.27 -25.26 12.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.369 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 19.8 m-85 -61.94 -60.67 3.29 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.778 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -48.14 -56.62 13.18 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 19.6 Cg_endo -59.29 -60.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.734 1.623 . . . . 0.0 112.439 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 64.4 m -61.89 -37.2 83.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.508 0.194 . . . . 0.0 111.459 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 6.3 tt0 -67.85 -40.62 83.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.889 0.376 . . . . 0.0 110.442 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -74.53 -30.12 61.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.809 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 71.3 mtp85 -82.87 -43.48 16.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.694 -177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 p -98.0 -40.33 8.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 0.0 111.281 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.37 -24.31 4.71 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.138 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLN . 59.7 m -127.18 147.14 60.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.628 0.251 . . . . 0.0 111.067 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 97.3 Cg_endo -79.9 1.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.023 2.482 . . . . 0.0 113.439 -175.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -58.01 100.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.39 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.86 21.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 35' ' ' TYR . 98.3 mttt -132.33 145.84 51.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.409 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -98.04 100.49 11.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.1 tp -133.35 134.94 56.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 60.03 34.92 21.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.539 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 5' ' ' ARG . 12.4 mmtp 60.26 28.46 18.06 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.065 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.3 p -145.85 124.68 12.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.72 0.295 . . . . 0.0 110.754 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 77.3 m -70.11 125.03 25.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.218 0.532 . . . . 0.0 111.809 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HD2' HD13 ' A' ' 1' ' ' ILE . 0.0 OUTLIER -99.35 93.55 5.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.187 174.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.3 m -70.23 131.73 44.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 26' ' ' LYS . 63.5 m-85 -105.85 -22.34 12.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.852 0.358 . . . . 0.0 110.651 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.04 -135.21 50.53 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.228 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 m -147.64 110.0 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.002 0.43 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.03 179.003 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 41.1 pt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -65.8 119.31 11.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 109.918 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.67 85.61 7.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.117 0.485 . . . . 0.0 111.397 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 74.8 mt -78.73 103.73 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -70.87 133.75 46.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.846 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 9.1 p -142.69 146.47 34.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.192 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.53 9.56 48.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.76 157.51 23.8 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 -29.78 70.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.208 0.527 . . . . 0.0 110.495 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.664 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 18.0 mtp180 -68.83 -13.5 62.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.864 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.51 -3.22 55.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.377 0.608 . . . . 0.0 109.674 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.1 m -105.15 -22.95 12.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.23 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 17.7 m-85 -63.65 -51.08 66.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.437 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.2 tmt_? -55.12 -54.32 51.73 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.504 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.0 Cg_endo -60.26 -59.66 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.745 1.63 . . . . 0.0 112.55 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 59.3 m -64.58 -37.45 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -171.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 17' ' ' GLN . 3.6 tt0 -68.23 -41.73 80.78 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.732 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 77.7 mtp180 -78.95 -55.73 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.695 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -90.75 -21.54 21.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.5 -10.43 57.77 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.092 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 29.4 m -132.24 139.78 35.96 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 122.784 -0.245 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.422 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 89.7 Cg_endo -79.44 5.19 6.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.973 2.449 . . . . 0.0 113.14 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -62.05 99.37 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.23 152.59 26.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.486 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -133.39 147.85 51.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.376 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.01 88.95 3.89 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.236 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -121.16 134.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -175.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 28' ' ' ILE . 90.0 m-20 60.33 32.06 20.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.861 0.362 . . . . 0.0 110.617 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt 56.54 31.99 20.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.9 p -135.72 125.63 25.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.556 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.743 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 87.6 m -68.42 115.82 8.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.435 0.636 . . . . 0.0 111.138 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -98.6 89.24 4.32 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.9 m -74.61 116.15 14.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.433 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -88.08 -38.92 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.265 0.555 . . . . 0.0 109.849 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 60.26 -129.4 47.53 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.752 177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.51 104.16 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.247 0.939 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.96 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.008 0.432 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -111.56 167.74 10.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.97 75.02 8.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.167 -174.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 78.2 mt -79.64 104.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 28.8 mmt180 -70.8 128.46 36.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.25 -176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -131.74 157.81 42.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.326 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.3 26.99 9.82 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.86 162.44 10.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 p -59.77 -32.59 70.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 110.821 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 46.5 mtm180 -68.73 -17.25 64.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.14 -16.03 39.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.5 0.667 . . . . 0.0 109.973 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.0 m -93.22 -13.74 27.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.49 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.6 m-30 -62.16 -60.41 3.64 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.4 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -49.47 -55.1 24.28 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 11.6 Cg_endo -58.0 -58.06 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.648 1.565 . . . . 0.0 112.326 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 43.4 m -67.46 -37.11 82.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.606 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 17' ' ' GLN . 1.0 OUTLIER -64.22 -36.94 85.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -81.98 -32.17 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.224 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 31.5 mtp180 -77.59 -39.61 45.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -111.53 -10.52 14.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.24 85.57 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.461 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 23' ' ' PRO . 37.9 t -141.42 138.85 17.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 85.7 Cg_endo -79.35 0.77 9.75 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.794 2.33 . . . . 0.0 114.081 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.12 100.95 0.1 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 111.132 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LYS . . . -150.79 151.51 32.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.579 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HE2' ' OH ' ' A' ' 35' ' ' TYR . 44.5 mtmt -120.53 142.51 49.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 t -93.53 65.61 3.76 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.448 0.642 . . . . 0.0 109.371 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' ND2' ' A' ' 29' ' ' ASN . 9.6 tp -98.31 134.19 37.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.833 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' ND2' HG13 ' A' ' 28' ' ' ILE . 51.6 m-80 62.18 24.78 14.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.96 0.409 . . . . 0.0 109.93 -174.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 61.22 26.93 16.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.391 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -129.15 137.93 51.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.859 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 71.4 m -77.53 120.87 23.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.907 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 6.4 tmtt? -98.04 93.67 6.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 4.3 m -78.99 111.0 14.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.719 0.295 . . . . 0.0 110.425 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' OH ' ' HE2' ' A' ' 26' ' ' LYS . 35.9 m-85 -80.17 -43.25 21.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.071 0.462 . . . . 0.0 110.137 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.5 166.7 16.31 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.25 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 29.2 m -149.48 73.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.863 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.286 0.565 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.94 30.14 7.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.24 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.43 76.18 0.2 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.64 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.768 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 61.4 mt -77.86 97.13 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -66.16 125.71 26.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.292 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 7.8 p -128.9 152.07 48.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.117 0.484 . . . . 0.0 111.78 -172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.41 28.59 8.15 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 171.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 11' ' ' ASP . . . 158.01 169.77 22.0 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -73.51 -31.21 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 22.9 mtp180 -76.0 -3.38 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.309 0.576 . . . . 0.0 110.644 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 m-20 -88.89 -12.22 42.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.04 -18.52 14.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.427 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 21.1 m-30 -60.89 -54.13 48.83 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -54.2 -56.71 23.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 118.348 0.522 . . . . 0.0 111.703 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 13.7 Cg_endo -58.51 -56.29 1.61 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.804 1.669 . . . . 0.0 112.239 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 58.6 m -63.6 -40.82 97.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -174.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -68.48 -40.17 81.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 0.0 110.297 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 38.0 tptt -73.22 -40.99 64.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.143 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 41.0 mtm180 -63.89 -59.8 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.273 0.559 . . . . 0.0 111.188 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.1 p -90.79 -23.97 20.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.796 -167.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.9 -15.9 36.84 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.889 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.62 141.43 41.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 122.715 -0.285 . . . . 0.0 110.573 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.09 2.75 8.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.211 2.608 . . . . 0.0 113.095 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -60.26 101.29 0.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.542 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.88 149.61 27.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.173 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -129.11 140.85 51.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.231 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.9 84.43 7.0 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.872 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG22 ' HB2' ' A' ' 33' ' ' LYS . 9.7 tp -106.12 132.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.307 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.25 37.42 28.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.316 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 64.03 19.08 11.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.385 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 p -132.09 133.37 44.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.957 0.408 . . . . 0.0 110.519 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.768 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 92.1 m -68.38 116.18 8.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.059 0.457 . . . . 0.0 111.115 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 28' ' ' ILE . 3.9 tmtm? -98.41 85.38 3.39 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.7 m -74.79 104.18 5.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.55 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -73.35 -34.63 65.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.485 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.53 -168.5 26.65 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.173 -173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.7 p -131.95 20.19 4.55 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.327 1.061 . . . . 0.0 109.133 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.395 -175.624 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.216 0.532 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' CD ' HH12 ' A' ' 19' ' ' ARG . 9.9 pt-20 -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.65 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 91.82 6.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.698 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 73.3 mt -79.28 102.99 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' NH1' HG23 ' A' ' 31' ' ' THR . 21.7 mmt180 -71.68 125.15 26.36 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.76 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 2.3 p -123.35 164.95 17.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.396 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.22 18.49 10.28 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.6 23.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -65.89 -37.01 84.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.17 0.51 . . . . 0.0 110.508 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 44.4 mtp180 -66.88 -17.09 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.215 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.17 -11.8 55.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.541 0.686 . . . . 0.0 109.653 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.9 m -101.45 -14.16 17.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.739 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 22.4 m-30 -59.83 -61.22 2.78 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.102 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' C ' ' HD3' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -52.26 -54.96 35.97 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.857 -173.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 7.1 Cg_endo -53.94 -61.75 0.4 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.98 1.787 . . . . 0.0 112.346 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 53.8 m -65.17 -35.83 82.32 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.556 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -64.97 -46.59 80.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -62.69 -42.05 99.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.349 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 18.6 mtp180 -75.45 -48.78 21.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.015 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -93.89 -42.93 8.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.802 0.334 . . . . 0.0 111.708 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -21.9 6.78 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' ' HA2' ' A' ' 36' ' ' GLY . 35.7 m -120.31 139.34 28.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.76 -0.49 10.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.902 2.402 . . . . 0.0 113.455 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -61.44 104.52 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.903 0.382 . . . . 0.0 110.858 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.47 146.17 20.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.948 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -126.73 143.04 51.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 0.0 110.557 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.7 t -90.16 80.66 6.25 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.522 HG13 ' ND2' ' A' ' 29' ' ' ASN . 10.8 tp -105.16 130.88 55.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.739 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' A' ' 28' ' ' ILE . 50.0 m-80 62.14 28.51 17.15 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.834 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.8 tttp 58.74 28.5 17.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.968 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' NH1' ' A' ' 5' ' ' ARG . 2.8 p -129.82 129.76 44.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.149 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 89.6 m -65.84 112.59 3.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -98.43 91.27 5.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 5.9 m -73.1 114.4 11.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 -175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.41 -33.58 19.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.199 0.524 . . . . 0.0 110.108 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 22' ' ' CYS . . . 57.43 -124.43 35.93 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.4 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.9 m -132.08 31.2 4.17 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.247 -175.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.24 147.48 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 110.907 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.14 91.74 7.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.357 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 81.3 mt -78.96 99.26 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 5' ' ' ARG . 12.5 mmt180 -65.73 133.99 52.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.81 -177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 32' ' ' CYS . 5.5 p -138.06 159.61 41.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.36 0.6 . . . . 0.0 112.147 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.54 38.18 2.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.1 171.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.84 163.09 9.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.031 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p -65.18 -35.09 80.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.964 0.411 . . . . 0.0 110.156 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 21.6 mtp180 -67.25 -15.27 63.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.905 177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 6' ' ' CYS . 31.1 t70 -94.65 -2.2 51.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.638 0.733 . . . . 0.0 109.631 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -107.86 -13.78 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.874 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 10' ' ' ARG . 22.9 m-85 -63.15 -55.77 22.37 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.769 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -50.63 -57.36 13.56 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.936 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 12.0 Cg_endo -57.28 -58.73 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.364 1.376 . . . . 0.0 112.084 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 36.3 m -65.45 -37.35 86.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.431 -174.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.768 HE21 ' HB3' ' A' ' 23' ' ' PRO . 32.7 tt0 -69.8 -39.9 76.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -67.3 -32.55 73.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.184 0.516 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 25.0 mtp180 -87.42 -47.98 8.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.8 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -94.65 -26.59 16.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.958 0.409 . . . . 0.0 111.723 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.98 -11.85 57.46 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.873 -175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -130.87 143.69 50.43 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 110.761 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.768 ' HB3' HE21 ' A' ' 17' ' ' GLN . 49.2 Cg_endo -86.61 7.64 4.82 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.293 2.662 . . . . 0.0 114.21 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.63 98.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.65 140.74 19.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.8 137.84 53.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.041 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 75.84 9.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.86 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 33' ' ' LYS . 8.5 tp -96.43 131.15 43.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.029 -175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.22 27.5 17.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 68.15 17.98 9.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.851 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 128.98 46.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.127 0.489 . . . . 0.0 110.677 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 6' ' ' CYS . 73.6 m -66.96 116.11 7.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.41 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 28' ' ' ILE . 6.2 tmtt? -98.25 88.04 4.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 3.5 m -72.83 112.02 8.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.982 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -88.42 -26.39 22.16 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.57 32.05 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.397 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.3 p -132.06 27.24 4.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.828 0.823 . . . . 0.0 109.969 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.09 -176.218 . . . . . . . . 0 0 . 1 stop_ save_